Isoform-specific toxicity of MeCP2 in postmitotic neurons: Suppression of neurotoxicity by FoxG1

Journal of Neuroscience

Volumn 32, Issue 8, 2012, Pages 2846-2855

  Dastidar, Somasish Ghosh ^a   Bardai, Farah H ^a   Ma, Chi ^a   Price, Valerie ^a   Rawat, Varun ^a   Verma, Pragya ^a   Narayanan, Vinodh ^b   D'Mello, Santosh R ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD BOX PROTEIN G1; FORKHEAD TRANSCRIPTION FACTOR; ISOPROTEIN; METHYL CPG BINDING PROTEIN 2; METHYL CPG BINDING PROTEIN 2 E1; METHYL CPG BINDING PROTEIN 2 E2; PROTEIN KINASE B; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; FEMALE; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; IMMUNOCYTOCHEMISTRY; IMMUNOPRECIPITATION; MALE; MOUSE; NERVE CELL; NERVE CELL NECROSIS; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; POSTMITOTIC NERVE CELL; PRIORITY JOURNAL; RAT; RETT SYNDROME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; CELLS, CULTURED; CEREBELLUM; DISEASE MODELS, ANIMAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUNTINGTON DISEASE; IMMUNOPRECIPITATION; INSULIN-LIKE GROWTH FACTOR I; MALE; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MITOSIS; MUTATION; NERVE TISSUE PROTEINS; NEURONS; NEUROTOXICITY SYNDROMES; NITRO COMPOUNDS; NUCLEAR PROTEINS; POTASSIUM; PROPIONIC ACIDS; PROTEIN ISOFORMS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 84857315949     PISSN: 02706474     EISSN: 15292401     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.5841-11.2012     Document Type: Article

References (45)

1. Ariani F, Hayek G, Rondinella D, Artuso R, Mencarelli MA, Spanhol-Rosseto A, Pollazzon M, Buoni S, Spiga O, Ricciardi S, Meloni I, Longo I, Mari F, Broccoli V, Zappella M, Renieri A (2008) FOXG1 is responsible for the congenital variant of Rett syndrome. Am J Hum Genet 83:89-93.
2. Bahi-Buisson N, Nectoux J, Girard B, Van Esch H, De Ravel T, Boddaert N, Plouin P, Rio M, Fichou Y, Chelly J, Bienvenu T (2010) Revisiting the phenotype associated with FOXG1 mutations: two novel cases of congenital Rett variant. Neurogenetics 11:241-249.
3. Bardai FH, D'Mello SR (2011) Selective toxicity by HDAC3 in neurons: regulation by akt and GSK3_. J Neurosci 31:1746-1751.
4. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, Miller JM, Storey E, Srivastava R, Rosen BR, Hyman BT (1993) Neurochemical and histological characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-Nitropropionic acid. J Neurosci 13:4181-4192.
5. Björkblom B, Vainio JC, Hongisto V, Herdegen T, Courtney MJ, Coffey ET (2008) All JNKs can kill, but nuclear localization is critical for neuronal death. J Biol Chem 283:19704-19713.
6. Calfa G, Percy AK, Pozzo-Miller L (2011) Experimental models of Rett syndrome based on Mecp2 dysfunction. Exp Biol Med (Maywood) 236:3-19.
7. Chahrour M, Zoghbi HY (2007) The story of Rett syndrome: from clinic to neurobiology. Neuron 56:422-437.
8. Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY (2008) MeCP2, a key contributor to neurological disease, activates and represses transcription. Science 320:1224-1229.
9. Chen HL, D'Mello SR (2010) Induction of neuronal cell death by paraneoplastic Ma1 antigen. J Neurosci Res 88:3508-3519.
10. Chen HM, Wang L, D'Mello SR (2008) A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. Eur J Neurosci 28:2003-2016.
11. Chin PC, Liu L, Morrison BE, Siddiq A, Ratan RR, Bottiglieri T, D'Mello SR (2004) The c-raf inhibitor GW5074 provides neuroprotection in vitro and in an animal model of neurodegeneration through a MEK-ERK and akt-independent mechanism. J Neurochem 90:595-608.
12. Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY (2004) Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet 13:2679-2689.
13. Dastidar SG, Landrieu PM, D'Mello SR (2011) FoxG1 promotes the survival of postmitotic neurons. J Neurosci 31:402-413.
14. Delgado-Esteban M, Martin-Zanca D, Andres-Martin L, Almeida A, Bolaños JP (2007) Inhibition of PTEN by peroxynitrite activates the phosphoinositide- 3-kinase/Akt neuroprotective signaling pathway. J Neurochem 102:194-205.
15. D'Mello SR, Galli C, Ciotti T, Calissano P (1993) Induction of apoptosis in cerebellar granule neurons by low potassium: inhibition of death by insulin-like growth factor I and cAMP. Proc Natl Acad Sci U S A 90:10989-10993.
16. Dragich JM, Kim YH, Arnold AP, Schanen NC (2007) Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J Comp Neurol 501:526-542.
17. Escartin C, Boyer F, Bemelmans AP, Hantraye P, Brouillet E (2007) IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats. Neurosci Lett 425:167-172.
18. Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice. J Neurosci 23: 9418-9427.
19. Gonzales ML, LaSalle JM (2010) The role of MeCP2 in brain development and neurodevelopmental disorders. Curr Psychiatry Rep 12:127-134.
20. Hanashima C, Shen L, Li SC, Lai E (2002) Brain factor-1 controls the proliferation and differentiation of neocortical progenitor cells through independent mechanisms. J Neurosci 22:6526-6536.
21. Hanashima C, Li SC, Shen L, Lai E, Fishell G (2004) Foxg1 suppresses early cortical cell fate. Science 303:56-59.
22. Hébert JM, McConnell SK (2000) Targeting of cre to the Foxg1 (BF-1) locus mediates loxP recombination in the telencephalon and other developing head structures. Dev Biol 222:296-306.
23. Hockly E, Richon VM, Woodman B, Smith DL, Zhou X, Rosa E, Sathasivam K, Ghazi-Noori S, Mahal A, Lowden PA, Steffan JS, Marsh JL, Thompson LM, Lewis CM, Marks PA, Bates GP (2003) Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc Natl Acad Sci U S A 100: 2041-2046.
24. Jacob FD, Ramaswamy V, Andersen J, Bolduc FV (2009) Atypical Rett syndrome with selective FOXG1 deletion detected by comparative genomic hybridization: case report and review of literature. Eur J Hum Genet 17:1577-1581.
25. Jung BP, Jugloff DG, Zhang G, Logan R, Brown S, Eubanks JH (2003) The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells. J Neurobiol 55:86-96.
26. Kishi N, Macklis JD (2004) MECP2 is progressively expressed in postmigratory neurons and is involved in neuronal maturation rather than cell fate decisions. Mol Cell Neurosci 27:306-321.
27. Kriaucionis S, Bird A (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res 32: 1818-1823.
28. Le Guen T, Bahi-Buisson N, Nectoux J, Boddaert N, Fichou Y, Diebold B, Desguerre I, Raqbi F, Daire VC, Chelly J, Bienvenu T (2011) A FOXG1 mutation in a boy with congenital variant of rett syndrome. Neurogenetics 12:1-8.
29. Li JY, Popovic N, Brundin P (2005) The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies. NeuroRx 2:447-464.
30. Luikenhuis S, Giacometti E, Beard CF, Jaenisch R (2004) Expression of MeCP2 in postmitotic neurons rescues rett syndrome in mice. Proc Natl Acad Sci U S A 101:6033-6038.
31. Ma C, D'Mello SR (2011) Neuroprotection by histone deacetylase-7 (HDAC7) occurs by inhibition of c-jun expression through a deacetylaseindependent mechanism. J Biol Chem 286:4819-4828.
32. Mangiarini L, Sathasivam K, Seller M, Cozens M, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP (1996) Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 87:493-506.
33. Meins M, Lehmann J, Gerresheim F, Herchenbach J, Hagedorn M, Hameister K, Epplen JT (2005) Submicroscopic duplication in Xq28 causes increased expression of the MECP2 gene in a boy with severe mental retardation and features of rett syndrome. J Med Genet 42:e12.
34. Mencarelli MA, Spanhol-Rosseto A, Artuso R, Rondinella D, De Filippis R, Bahi-Buisson N, Nectoux J, Rubinsztajn R, Bienvenu T, Moncla A, Chabrol B, Villard L, Krumina Z, Armstrong J, Roche A, Pineda M, Gak E, Mari F, Ariani F, Renieri A (2010) Novel FOXG1 mutations associated with the congenital variant of rett syndrome. J Med Genet 47:49-53.
35. Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, Jones JR, Scherer SW, Schanen NC, Friez MJ, Vincent JB, Minassian BA (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to rett syndrome. Nat Genet 36:339-341.
36. Philippe C, Amsallem D, Francannet C, Lambert L, Saunier A, Verneau F, Jonveaux P (2010) Phenotypic variability in rett syndrome associated with FOXG1 mutations in females. J Med Genet 47:59-65.
37. Reardon W, Donoghue V, Murphy AM, King MD, Mayne PD, Horn N, Birk Møller L (2010) Progressive cerebellar degenerative changes in the severe mental retardation syndrome caused by duplication of MECP2 and adjacent loci on Xq28. Eur J Pediatr 169:941-949.
38. Russell JC, Blue ME, Johnston MV, Naidu S, Hossain MA (2007) Enhanced cell death in MeCP2 null cerebellar granule neurons exposed to excitotoxicity and hypoxia. Neuroscience 150:563-574.
39. Shi J, Shibayama A, Liu Q, Nguyen VQ, Feng J, Santos M, Temudo T, Maciel P, Sommer SS (2005) Detection of heterozygous deletions and duplications in the MECP2 gene in rett syndrome by robust dosage PCR (RDPCR). Hum Mutat 25:505.
40. Siegenthaler JA, Tremper-Wells BA, Miller MW (2008) Foxg1 haploinsufficiency reduces the population of cortical intermediate progenitor cells: effect of increased p21 expression. Cereb Cortex 18:1865-1875.
41. Tao W, Lai E (1992) Telencephalon-restricted expression of BF-1, a new member of the HNF-3/fork head gene family, in the developing rat brain. Neuron 8:957-966.
42. Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, SurM (2009) Partial reversal of rett syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci USA 106:2029-2034.
43. Wang L, Ankati H, Akubathini SK, Balderamos M, Storey CA, Patel AV, Price V, Kretzschmar D, Biehl ER, D'Mello SR (2010) Identification of novel 1,4-benzoxazine compounds that are protective in tissue culture and in vivo models of neurodegeneration. J Neurosci Res 88:1970-1984.
44. Xuan S, Baptista CA, Balas G, Tao W, Soares VC, Lai E (1995) Winged helix transcription factor BF-1 is essential for the development of the cerebral hemispheres. Neuron 14:1141-1152.
45. Yasui DH, Peddada S, Bieda MC, Vallero RO, Hogart A, Nagarajan RP, Thatcher KN, Farnham PJ, Lasalle JM (2007) Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Proc Natl Acad Sci U S A 104:19416-19421.